Biologic And Small Molecule Drug Substance CDMO Selection Metrics Align
Source: Life Science Leader
By Industry Standard Research
ISR’s annual CDMO Benchmarking research asks participants to identify the CDMO attributes that factor into their service provider selection decision. Four out of five of the top metrics sync up among drug substance outsourcers for biologics and small molecules. However, among large molecule outsourcers, a Track record for meeting quality performance metrics made the top five but landed in 8th position among small molecule outsourcers. Conversely, small molecule outsourcers prized a Proven ability to manufacture small molecule API while this attribute ranked 6th for biologic outsourcers.
VIEW THE MAGAZINE ARTICLE!
Log In
Signing up provides unlimited access to:
Free Sign Up

Signing up provides unlimited access to:
- Trend and Leadership Articles
- Case Studies
- Extensive Product Database
- Premium Content
HELLO. PLEASE LOG IN.
X
Not yet a member of Life Science Leader? Register today.
ACCOUNT SIGN UP
X
Please fill in your account details
ACCOUNT SIGN UP
This website uses cookies to ensure you get the best experience on our website. Learn more